Ken Griffin Axonics, Inc. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$67.3 - $69.67 $2.15 Million - $2.23 Million	32,000 Added 121.67%	58,300 $4.06 Million
Q2 2024 Aug 14, 2024	BUY	$66.47 - $69.65 $1.24 Million - $1.3 Million	18,600 Added 241.56%	26,300 $1.77 Million
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $544,032 - $665,856	-9,600 Reduced 55.49%	7,700 $531,000
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $133,326 - $172,125	2,700 Added 18.49%	17,300 $1.08 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $184,832 - $237,538	3,800 Added 35.19%	14,600 $819,000
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $422,312 - $529,848	8,800 Added 440.0%	10,800 $545,000
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $36,820 - $47,138	700 Added 53.85%	2,000 $109,000
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $77,428 - $99,579	1,300 New	1,300 $81,000

235

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.